Beclomethasone Interaction with other Drugs

4-Phenylbutyric Acid

The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Beclomethasone dipropionate.

Aceclofenac

The risk or severity of adverse effects can be increased when Aceclofenac is combined with Beclomethasone dipropionate.

Acemetacin

The risk or severity of adverse effects can be increased when Acemetacin is combined with Beclomethasone dipropionate.

Acetyl salicylate

The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Beclomethasone dipropionate.

Adapalene

The risk or severity of adverse effects can be increased when Adapalene is combined with Beclomethasone dipropionate.

Aldesleukin

Beclomethasone dipropionate may decrease the antineoplastic activities of Aldesleukin.

Alminoprofen

The risk or severity of adverse effects can be increased when Alminoprofen is combined with Beclomethasone dipropionate.

Aloxiprin

The risk or severity of adverse effects can be increased when Aloxiprin is combined with Beclomethasone dipropionate.

Aluminum

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Aluminium.

Aluminum Hydroxide

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Aluminum hydroxide.

aluminum hydroxide, dried (USP)

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Aluminum hydroxide.

Aluminum Magnesium Silicate

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Almasilate.

Ambenonium

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Ambenonium.

Aminosalicylic Acid

The risk or severity of adverse effects can be increased when Aminosalicylic Acid is combined with Beclomethasone dipropionate.

Amiodarone

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Amiodarone.

Amoxapine

The therapeutic efficacy of Beclomethasone dipropionate can be decreased when used in combination with Amoxapine.

Amphotericin B

Beclomethasone dipropionate may increase the hypokalemic activities of Amphotericin B.

amphotericin B liposomal

Beclomethasone dipropionate may increase the hypokalemic activities of Amphotericin B.

Anthrax immune globulin, human

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Anthrax immune globulin human.

Antipyrine

The risk or severity of adverse effects can be increased when Antipyrine is combined with Beclomethasone dipropionate.

Apalutamide

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Apalutamide.

Apazone

The risk or severity of adverse effects can be increased when Azapropazone is combined with Beclomethasone dipropionate.

Apremilast

The risk or severity of adverse effects can be increased when Apremilast is combined with Beclomethasone dipropionate.

Aprepitant

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Aprepitant.

Aripiprazole

The serum concentration of Aripiprazole can be decreased when it is combined with Beclomethasone dipropionate.

Aspirin

The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Beclomethasone dipropionate.

Atazanavir

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Atazanavir.

Atracurium Besylate

Atracurium besylate may increase the adverse neuromuscular activities of Beclomethasone dipropionate.

Azelastine

The risk or severity of adverse effects can be increased when Azelastine is combined with Beclomethasone dipropionate.

Azosemide

Beclomethasone dipropionate may increase the hypokalemic activities of Azosemide.

Balsalazide

The risk or severity of adverse effects can be increased when Balsalazide is combined with Beclomethasone dipropionate.

BCG Vaccine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with BCG vaccine.

BCG, Live, Connaught Strain

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Bacillus calmette-guerin substrain connaught live antigen.

BCG, Live, Tice Strain

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Bacillus calmette-guerin substrain tice live antigen.

Bendroflumethiazide

Beclomethasone dipropionate may increase the hypokalemic activities of Bendroflumethiazide.

Benzoic Acid

The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Beclomethasone dipropionate.

Benzydamine

The risk or severity of adverse effects can be increased when Benzydamine is combined with Beclomethasone dipropionate.

Bismuth Subcitrate

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Bismuth Subcitrate.

Boceprevir

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Boceprevir.

Bromfenac

The risk or severity of adverse effects can be increased when Bromfenac is combined with Beclomethasone dipropionate.

Bufexamac

The risk or severity of adverse effects can be increased when Bufexamac is combined with Beclomethasone dipropionate.

Bumetanide

Beclomethasone dipropionate may increase the hypokalemic activities of Bumetanide.

Calcitriol

The therapeutic efficacy of Calcitriol can be decreased when used in combination with Beclomethasone dipropionate.

Calcium Carbonate

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Calcium Carbonate.

CALCIUM CARBONATE, PRECIPITATED

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Calcium Carbonate.

Capromab Pendetide

Beclomethasone dipropionate may decrease effectiveness of Capromab pendetide as a diagnostic agent.

Carbamazepine

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Carbamazepine.

Carprofen

The risk or severity of adverse effects can be increased when Carprofen is combined with Beclomethasone dipropionate.

Celecoxib

The risk or severity of adverse effects can be increased when Celecoxib is combined with Beclomethasone dipropionate.

Ceritinib

Beclomethasone dipropionate may increase the hyperglycemic activities of Ceritinib.

Chloroquine

The risk or severity of adverse effects can be increased when Chloroquine is combined with Beclomethasone dipropionate.

Chlorothiazide

Beclomethasone dipropionate may increase the hypokalemic activities of Chlorothiazide.

Chlorotrianisene

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Chlorotrianisene.

Chlorthalidone

Beclomethasone dipropionate may increase the hypokalemic activities of Chlorthalidone.

Cholestyramine Resin

Cholestyramine can cause a decrease in the absorption of Beclomethasone dipropionate resulting in a reduced serum concentration and potentially a decrease in efficacy.

Choline Magnesium Trisalicyclate

The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Beclomethasone dipropionate.

Cinoxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Cinoxacin.

Clarithromycin

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Clarithromycin.

Clonixin

The risk or severity of adverse effects can be increased when Clonixin is combined with Beclomethasone dipropionate.

Cobicistat

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Cobicistat.

Colesevelam

Colesevelam can cause a decrease in the absorption of Beclomethasone dipropionate resulting in a reduced serum concentration and potentially a decrease in efficacy.

Colestipol

Colestipol can cause a decrease in the absorption of Beclomethasone dipropionate resulting in a reduced serum concentration and potentially a decrease in efficacy.

Corticorelin Ovine

The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Beclomethasone dipropionate.

Corticorelin Ovine Triflutate

The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Beclomethasone dipropionate.

Curcumin

The risk or severity of adverse effects can be increased when Curcumin is combined with Beclomethasone dipropionate.

Cyclopenthiazide

Beclomethasone dipropionate may increase the hypokalemic activities of Cyclopenthiazide.

Danazol

Beclomethasone dipropionate may increase the fluid retaining activities of Danazol.

Darunavir

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Darunavir.

Deferasirox

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Deferasirox.

Demecarium

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Demecarium.

Diclofenac

The risk or severity of adverse effects can be increased when Diclofenac is combined with Beclomethasone dipropionate.

Dienestrol

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Dienestrol.

Diethylstilbestrol

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Diethylstilbestrol.

Diflunisal

The risk or severity of adverse effects can be increased when Diflunisal is combined with Beclomethasone dipropionate.

Dipyrone

The risk or severity of adverse effects can be increased when Metamizole is combined with Beclomethasone dipropionate.

Distigmine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Distigmine.

Donepezil

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Donepezil.

Droxicam

The risk or severity of adverse effects can be increased when Droxicam is combined with Beclomethasone dipropionate.

Echothiophate

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Echothiophate.

Edrophonium

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Edrophonium.

Enoxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Enoxacin.

Enzalutamide

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Enzalutamide.

Equol, (-)-

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Equol.

Estradiol

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Estradiol.

Estradiol acetate

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Estradiol acetate.

Estradiol Cypionate

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Estradiol cypionate.

Estradiol Valerate

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Estradiol valerate.

Estriol

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Estriol.

Estrogens, Conjugated (USP)

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Conjugated estrogens.

Estrogens, Esterified (USP)

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Estrogens, esterified.

Estrone

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Estrone.

Etanercept

The risk or severity of adverse effects can be increased when Etanercept is combined with Beclomethasone dipropionate.

Ethacrynate

Beclomethasone dipropionate may increase the hypokalemic activities of Etacrynic acid.

Ethacrynic Acid

Beclomethasone dipropionate may increase the hypokalemic activities of Etacrynic acid.

Ethinyl Estradiol

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Ethinyl Estradiol.

Etodolac

The risk or severity of adverse effects can be increased when Etodolac is combined with Beclomethasone dipropionate.

Etofenamate

The risk or severity of adverse effects can be increased when Etofenamate is combined with Beclomethasone dipropionate.

Etoricoxib

The risk or severity of adverse effects can be increased when Etoricoxib is combined with Beclomethasone dipropionate.

Evening primrose oil

The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Beclomethasone dipropionate.

Felbinac

The risk or severity of adverse effects can be increased when Felbinac is combined with Beclomethasone dipropionate.

Fenbufen

The risk or severity of adverse effects can be increased when Fenbufen is combined with Beclomethasone dipropionate.

Fenoprofen

The risk or severity of adverse effects can be increased when Fenoprofen is combined with Beclomethasone dipropionate.

Ferulic Acid

The risk or severity of adverse effects can be increased when Ferulic acid is combined with Beclomethasone dipropionate.

Fleroxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Fleroxacin.

Floctafenine

The risk or severity of adverse effects can be increased when Floctafenine is combined with Beclomethasone dipropionate.

Flumequine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Flumequine.

Fluoxymesterone

Beclomethasone dipropionate may increase the fluid retaining activities of Fluoxymesterone.

Flurbiprofen

The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Beclomethasone dipropionate.

Fosaprepitant

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Fosaprepitant.

Fosphenytoin

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Fosphenytoin.

Furosemide

Beclomethasone dipropionate may increase the hypokalemic activities of Furosemide.

Galantamine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Galantamine.

Gallamine Triethiodide

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Gallamine Triethiodide.

Gatifloxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Gatifloxacin.

Gatifloxacin Anhydrous

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Gatifloxacin.

Gemifloxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Gemifloxacin.

Gemifloxacin Mesylate

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Gemifloxacin.

Genistein

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Genistein.

Ginkgo biloba extract

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Ginkgo biloba.

Glycerol Phenylbutyrate

The therapeutic efficacy of Glycerol Phenylbutyrate can be decreased when used in combination with Beclomethasone dipropionate.

Grepafloxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Grepafloxacin.

Hepatitis A Vaccine, Inactivated

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Hepatitis A Vaccine.

Hepatitis B Surface Antigen Vaccine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Hepatitis B Vaccine (Recombinant).

Hyaluronidase

The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Beclomethasone dipropionate.

Hyaluronidase, Ovine

The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Beclomethasone dipropionate.

Hydrochlorothiazide

Beclomethasone dipropionate may increase the hypokalemic activities of Hydrochlorothiazide.

Hydroflumethiazide

Beclomethasone dipropionate may increase the hypokalemic activities of Hydroflumethiazide.

Hydrotalcite

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Hydrotalcite.

Hypoxis hemerocallidea root extract

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with St. John's Wort.

Ibuprofen

The risk or severity of adverse effects can be increased when Ibuprofen is combined with Beclomethasone dipropionate.

Icatibant

The risk or severity of adverse effects can be increased when Icatibant is combined with Beclomethasone dipropionate.

Idelalisib

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Idelalisib.

Indacaterol

Indacaterol may increase the hypokalemic activities of Beclomethasone dipropionate.

Indapamide

Beclomethasone dipropionate may increase the hypokalemic activities of Indapamide.

Indinavir

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Indinavir.

INDINAVIR ANHYDROUS

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Indinavir.

Indobufen

The risk or severity of adverse effects can be increased when Indobufen is combined with Beclomethasone dipropionate.

Indomethacin

The risk or severity of adverse effects can be increased when Indomethacin is combined with Beclomethasone dipropionate.

Isoflurophate

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Isoflurophate.

Isoniazid

The serum concentration of Isoniazid can be decreased when it is combined with Beclomethasone dipropionate.

Itraconazole

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Itraconazole.

Kebuzone

The risk or severity of adverse effects can be increased when Kebuzone is combined with Beclomethasone dipropionate.

Ketoconazole

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Ketoconazole.

Ketoprofen

The risk or severity of adverse effects can be increased when Ketoprofen is combined with Beclomethasone dipropionate.

Ketorolac

The risk or severity of adverse effects can be increased when Ketorolac is combined with Beclomethasone dipropionate.

Lacidipine

The serum concentration of Lacidipine can be decreased when it is combined with Beclomethasone dipropionate.

Leflunomide

The risk or severity of adverse effects can be increased when Leflunomide is combined with Beclomethasone dipropionate.

Levofloxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Levofloxacin.

Levofloxacin Anhydrous

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Levofloxacin.

Limonene, (+)-

The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Beclomethasone dipropionate.

Lopinavir

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Lopinavir.

Lornoxicam

The risk or severity of adverse effects can be increased when Lornoxicam is combined with Beclomethasone dipropionate.

Loxoprofen

The risk or severity of adverse effects can be increased when Loxoprofen is combined with Beclomethasone dipropionate.

Lumacaftor

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Lumacaftor.

Magaldrate

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Magaldrate.

Magnesium Hydroxide

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Magnesium hydroxide.

Magnesium Oxide

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Magnesium oxide.

Magnesium Salicylate

The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Beclomethasone dipropionate.

Magnesium Trisilicate

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Magnesium Trisilicate.

Malathion

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Malathion.

Masoprocol

The risk or severity of adverse effects can be increased when Masoprocol is combined with Beclomethasone dipropionate.

Meclofenamate

The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Beclomethasone dipropionate.

Meclofenamic Acid

The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Beclomethasone dipropionate.

Mefenamic Acid

The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Beclomethasone dipropionate.

Mefloquine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Mefloquine.

Meloxicam

The risk or severity of adverse effects can be increased when Meloxicam is combined with Beclomethasone dipropionate.

Memantine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Memantine.

Mesalamine

The risk or severity of adverse effects can be increased when Mesalazine is combined with Beclomethasone dipropionate.

Mesterolone

Beclomethasone dipropionate may increase the fluid retaining activities of Mesterolone.

Mestranol

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Mestranol.

Methyclothiazide

Beclomethasone dipropionate may increase the hypokalemic activities of Methyclothiazide.

Methyl Salicylate

The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Beclomethasone dipropionate.

Methyltestosterone

Beclomethasone dipropionate may increase the fluid retaining activities of Methyltestosterone.

Metoclopramide

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Metoclopramide.

Metolazone

Beclomethasone dipropionate may increase the hypokalemic activities of Metolazone.

Mifepristone

The therapeutic efficacy of Beclomethasone dipropionate can be decreased when used in combination with Mifepristone.

Minaprine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Minaprine.

Mitotane

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Mitotane.

Mivacurium

Mivacurium may increase the adverse neuromuscular activities of Beclomethasone dipropionate.

MYCOPHENOLATE

The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Beclomethasone dipropionate.

Mycophenolate Mofetil

The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Beclomethasone dipropionate.

Mycophenolic Acid

The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Beclomethasone dipropionate.

Nabumetone

The risk or severity of adverse effects can be increased when Nabumetone is combined with Beclomethasone dipropionate.

Naftifine

The risk or severity of adverse effects can be increased when Naftifine is combined with Beclomethasone dipropionate.

Nalidixic Acid

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Nalidixic Acid.

Nandrolone

Beclomethasone dipropionate may increase the fluid retaining activities of Nandrolone.

Nandrolone Decanoate

Beclomethasone dipropionate may increase the fluid retaining activities of Nandrolone decanoate.

Naproxen

The risk or severity of adverse effects can be increased when Naproxen is combined with Beclomethasone dipropionate.

Nefazodone

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Nefazodone.

Nelfinavir

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Nelfinavir.

Neostigmine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Neostigmine.

Nepafenac

The risk or severity of adverse effects can be increased when Nepafenac is combined with Beclomethasone dipropionate.

Nevirapine

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Nevirapine.

Nicorandil

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Nicorandil.

Niflumic Acid

The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Beclomethasone dipropionate.

Nimesulide

The risk or severity of adverse effects can be increased when Nimesulide is combined with Beclomethasone dipropionate.

Norfloxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Norfloxacin.

O-PHENANTHROLINE

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with 1,10-Phenanthroline.

Oenothera biennis seed extract

The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Beclomethasone dipropionate.

Olopatadine

The risk or severity of adverse effects can be increased when Olopatadine is combined with Beclomethasone dipropionate.

Olsalazine

The risk or severity of adverse effects can be increased when Olsalazine is combined with Beclomethasone dipropionate.

Oxandrolone

Beclomethasone dipropionate may increase the fluid retaining activities of Oxandrolone.

Oxaprozin

The risk or severity of adverse effects can be increased when Oxaprozin is combined with Beclomethasone dipropionate.

Oxymetholone

Beclomethasone dipropionate may increase the fluid retaining activities of Oxymetholone.

Oxyphenbutazone

The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Beclomethasone dipropionate.

Parecoxib

The risk or severity of adverse effects can be increased when Parecoxib is combined with Beclomethasone dipropionate.

Parthenolide

The risk or severity of adverse effects can be increased when Parthenolide is combined with Beclomethasone dipropionate.

Pefloxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Pefloxacin.

Pentobarbital

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Pentobarbital.

Phenobarbital

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Phenobarbital.

Phenylacetic Acid

The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Beclomethasone dipropionate.

Phenylbutazone

The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Beclomethasone dipropionate.

Phenylbutyrate

The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Beclomethasone dipropionate.

Phenytoin

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Phenytoin.

Physostigmine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Physostigmine.

Pimecrolimus

The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Beclomethasone dipropionate.

Piretanide

Beclomethasone dipropionate may increase the hypokalemic activities of Piretanide.

Pirfenidone

The risk or severity of adverse effects can be increased when Pirfenidone is combined with Beclomethasone dipropionate.

Piroxicam

The risk or severity of adverse effects can be increased when Piroxicam is combined with Beclomethasone dipropionate.

Piroxicam-Beta-Cyclodextrin

The risk or severity of adverse effects can be increased when Piroxicam is combined with Beclomethasone dipropionate.

Polyestradiol Phosphate

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Polyestradiol phosphate.

Polythiazide

Beclomethasone dipropionate may increase the hypokalemic activities of Polythiazide.

Posaconazole

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Posaconazole.

Primidone

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Primidone.

Promestriene

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Promestriene.

Pyridostigmine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Pyridostigmine.

Pyridostigmine Bromide

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Pyridostigmine.

Quinestrol

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Quinestrol.

Quinethazone

Beclomethasone dipropionate may increase the hypokalemic activities of Quinethazone.

Rabies Immune Globulin, Human

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Human rabies virus immune globulin.

Rabies Virus Vaccine Flury-Lep Strain

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Rabies virus inactivated antigen, A.

Rapacuronium

Rapacuronium may increase the adverse neuromuscular activities of Beclomethasone dipropionate.

Resveratrol

The risk or severity of adverse effects can be increased when Resveratrol is combined with Beclomethasone dipropionate.

Rifabutin

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Rifabutin.

Rifampin

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Rifampicin.

Rifapentine

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Rifapentine.

Rilpivirine

The serum concentration of Rilpivirine can be decreased when it is combined with Beclomethasone dipropionate.

Rivastigmine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Rivastigmine.

Rofecoxib

The risk or severity of adverse effects can be increased when Rofecoxib is combined with Beclomethasone dipropionate.

Rosoxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Rosoxacin.

ROTAVIRUS VACCINE, LIVE

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Rotavirus Vaccine.

Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Rubella virus vaccine.

Salicylamide

The risk or severity of adverse effects can be increased when Salicylamide is combined with Beclomethasone dipropionate.

Salicylic Acid

The risk or severity of adverse effects can be increased when Salicylic acid is combined with Beclomethasone dipropionate.

Salmonella enterica subsp. enterica serovar typhi

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Salmonella typhi ty21a live antigen.

Salsalate

The risk or severity of adverse effects can be increased when Salsalate is combined with Beclomethasone dipropionate.

Saquinavir

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Saquinavir.

Saquinavir Mesylate

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Saquinavir.

Saxagliptin

The serum concentration of Saxagliptin can be decreased when it is combined with Beclomethasone dipropionate.

Saxagliptin Anhydrous

The serum concentration of Saxagliptin can be decreased when it is combined with Beclomethasone dipropionate.

Serratiopeptidase

The risk or severity of adverse effects can be increased when Serrapeptase is combined with Beclomethasone dipropionate.

Sodium Bicarbonate

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Sodium bicarbonate.

Sparfloxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Sparfloxacin.

ST. JOHN'S WORT EXTRACT

The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with St. John's Wort.

Stanozolol

Beclomethasone dipropionate may increase the fluid retaining activities of Stanozolol.

Sulfasalazine

The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Beclomethasone dipropionate.

Sulindac

The risk or severity of adverse effects can be increased when Sulindac is combined with Beclomethasone dipropionate.

Suprofen

The risk or severity of adverse effects can be increased when Suprofen is combined with Beclomethasone dipropionate.

synthetic conjugated estrogens, A

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Synthetic Conjugated Estrogens, A.

synthetic conjugated estrogens, B

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Synthetic Conjugated Estrogens, B.

Tacrine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Tacrine.

Telaprevir

The serum concentration of Telaprevir can be decreased when it is combined with Beclomethasone dipropionate.

Telithromycin

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Telithromycin.

Temafloxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Temafloxacin.

Tenoxicam

The risk or severity of adverse effects can be increased when Tenoxicam is combined with Beclomethasone dipropionate.

Teriflunomide

The risk or severity of adverse effects can be increased when Teriflunomide is combined with Beclomethasone dipropionate.

Testosterone

Beclomethasone dipropionate may increase the fluid retaining activities of Testosterone.

Testosterone Cypionate

The risk or severity of edema formation can be increased when Testosterone cypionate is combined with Beclomethasone dipropionate.

Testosterone Enanthate

The risk or severity of edema formation can be increased when Testosterone enanthate is combined with Beclomethasone dipropionate.

Testosterone Propionate

Beclomethasone dipropionate may increase the fluid retaining activities of Testosterone propionate.

Testosterone Undecanoate

The risk or severity of fluid retention can be increased when Testosterone undecanoate is combined with Beclomethasone dipropionate.

Tetanus Toxoid Vaccine, Inactivated

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).

Tiaprofenic Acid

The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Beclomethasone dipropionate.

Tibolone

The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Tibolone.

Tolfenamic Acid

The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Beclomethasone dipropionate.

Tolmetin

The risk or severity of adverse effects can be increased when Tolmetin is combined with Beclomethasone dipropionate.

Torsemide

Beclomethasone dipropionate may increase the hypokalemic activities of Torasemide.

Tranilast

The risk or severity of adverse effects can be increased when Tranilast is combined with Beclomethasone dipropionate.

Trichlormethiazide

Beclomethasone dipropionate may increase the hypokalemic activities of Trichlormethiazide.

Trolamine Salicylate

The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Beclomethasone dipropionate.

Tromethamine

The bioavailability of Beclomethasone dipropionate can be decreased when combined with Tromethamine.

Trovafloxacin

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Trovafloxacin.

Tubocurarine

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Tubocurarine.

Typhoid Vaccine Live Ty21a

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Salmonella typhi ty21a live antigen.

Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Salmonella typhi ty2 vi polysaccharide antigen.

Valdecoxib

The risk or severity of adverse effects can be increased when Valdecoxib is combined with Beclomethasone dipropionate.

Varicella Virus Vaccine Live (Oka-Merck) strain

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Varicella Zoster Vaccine (Live/Attenuated).